Intrinsic Value
Adaptimmune Therapeutics plc (ADAP)
$0.8984
-0.09 (-8.98%)
| Enterprise Value | -2,350,718.51 |
|---|---|
| Net Debt | -118.76 |
| Equity Value | -2,350,599.75 |
| Shares Outstanding | 201.07 |
| Equity Value Per Share | -11,690.25 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt